Altimmune to Present Results of Pemvidutide in MASH in an Oral Presentation and Multiple Poster Presentations at EASL Congress 2026
Go back to Altimmune to Present Results of Pemvidutide in MASH in an Oral Presentation and Multiple Poster Presentations at EASL Congress 2026| iShares Diversified Alternatives Trust (NASDAQ: ALT) | Delayed: 2.93 +0.23 (8.52%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.70 | 52 Week High | $54.24 | |||
| Open | $2.84 | 52 Week Low | $48.35 | |||
| Day High | $3.05 | P/E | N/A | |||
| Day Low | $2.83 | EPS | $0.00 | |||
| Volume | 5,771,010 | |||||
